Delivery Order SPE2DB20D3103-SPE2DB25FP0A8
- Not listed
- The Defense Logistics Agency awarded a $11,834.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors on July 14, 2025, with completion targeted for July 15, 2025. This non-set-aside competitive award will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a $4,683.69 delivery order to AmerisourceBergen Drug Corp on November 20, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors. This competitively awarded, firm fixed-price contract with no set-aside designation is scheduled for completion by November 21, 2025, and will be fulfilled from the contractor's Conshohocken, Pennsylvania facility. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $9,026.09 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mounjaro 10 mg/0.5 ml pen injectors (0.5 ml). This is a non-set-aside competitive award with performance to be completed by July 29, 2025, and will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- The Defense Logistics Agency awarded a $3,521.86 delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. This non-set-aside, firm fixed-price contract is scheduled for completion by August 14, 2025, with performance based in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- The Defense Logistics Agency awarded a $33,391.18 delivery order to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on August 18, 2025, with an ultimate completion date of August 19, 2025. This is a firm fixed price, non-set-aside contract performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, a...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $5,060.15 to AmerisourceBergen Drug Corp on November 17, 2025, for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors. The delivery order, which is not set-aside, represents performance to be completed by November 18, 2025, at the contractor's corporate office location in Conshohocken, Pennsylvania. This competitively awarded order falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a delivery order valued at $2,992.99 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 mL pen injectors on October 22, 2025. This firm fixed price, non-set-aside contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026. The work will be performed at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $11,113.37 for Mounjaro 2.5 mg/0.5 mL pen injectables, with an ultimate completion date of July 23, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The place of performance is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $1,994.92 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Mounjaro 7.5 mg/0.5 ml pen injectors. This competitive award, with no set-aside designation, is scheduled for completion by July 29, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA...
- The Defense Logistics Agency awarded a delivery order valued at $3,550.08 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors on November 13, 2025, with completion scheduled for November 14, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and is performed at the contractor's facility in Conshohocken, Pennsylvania. The award represents a single delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB25FP0A8Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,079.02 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 ml pen injectors on May 30, 2025, with completion scheduled for June 2, 2025. This non-set-aside, firm fixed-price delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, supplies a comprehensive range of medical products to federal healthcare systems, including the Defense Health Agency and U.S. Coast Guard. As a prime contractor under the DLA Troop Support Medical vehicle, the company fulfills delivery orders for brand-name and generic pharmaceuticals, vaccines, medical devices, and specialty medications across multiple therapeutic domains to support military healthcare programs worldwide. This delivery order for Mounjaro, a diabetes medication, represents a routine fulfillment under the broader pharmaceutical prime vendor arrangement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.1k | 5/30/25 |